LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引：2
作者：
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：9A / 14A
页数：6
相关论文
共 50 条
[41]   Dupilumab efficacy in severe asthma exacerbations by different baseline patient characteristics in patients with uncontrolled persistent asthma [J].
Fabbri, L. M. ;
Bernstein, J. A. ;
Staudinger, H. ;
Maroni, J. ;
Rowe, P. ;
Jayawardena, S. ;
Joish, V. N. ;
Eckert, L. ;
Amin, N. ;
Akinlade, B. ;
Pirozzi, G. ;
Graham, N. M. ;
Teper, A. .
ALLERGY, 2017, 72 :108-109
[42]   Effect of Tezepelumab on Airway Hyperresponsiveness by Baseline Blood Eosinophil Count in Patients With Severe, Uncontrolled Asthma in the Phase 2 CASCADE Study [J].
Brightling, C. E. ;
O'Byrne, P. M. ;
Porsbjerg, C. ;
Boulet, L. ;
Martin, N. ;
Molfino, N. A. ;
Megally, A. ;
Griffiths, J. M. ;
Clarke, D. ;
Martin, N. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[43]   Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer [J].
Shahjehan, Faisal ;
Merchea, Amit ;
Cochuyt, Jordan J. ;
Li, Zhuo ;
Colibaseanu, Dorin T. ;
Kasi, Pashtoon Murtaza .
FRONTIERS IN ONCOLOGY, 2018, 8
[44]   Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR (vol 16, pg 915, 2023) [J].
Laidlaw, Tm ;
Menzies-Gow, A. ;
Caveney, S. .
JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 :1053-1053
[45]   Effect of Tezepelumab on Exercise Tolerance in Patients With Severe, Uncontrolled Asthma From the NAVIGATOR Study [J].
Lugogo, N. L. ;
Kraft, M. ;
Corren, J. ;
Martin, N. ;
Shenoy, K. V. ;
Shenoy, S. F. ;
Chandarana, S. ;
Ambrose, C. S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[46]   Characteristics of exacerbations in patients with severe, uncontrolled asthma who received tezepelumab versus placebo [J].
Bourdin, Arnaud ;
Wechsler, Michael E. ;
Brightling, Christopher E. ;
Korn, Stephanie ;
Brusselle, Guy ;
Heaney, Liam G. ;
Ponnarambil, Sandhia ;
Hunter, Gillian ;
Lindsley, Andrew W. ;
Ambrose, Christopher S. .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[47]   Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR) [J].
Pavord, Ian D. ;
Hoyte, Flavia C. L. ;
Lindsley, Andrew W. ;
Ambrose, Christopher S. ;
Spahn, Joseph D. ;
Roseti, Stephanie L. ;
Cook, Bill ;
Grif, Janet M. ;
Hellqvist, Asa ;
Martin, Nicole ;
Llanos, Jean-Pierre ;
Martin, Neil ;
Colice, Gene ;
Corren, Jonathan .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) :587-597.e3
[48]   Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY [J].
Corren, Jonathan ;
Garcia Gil, Esther ;
Griffiths, Janet M. ;
Parnes, Jane R. ;
van der Merwe, Rene ;
Salapa, Kinga ;
O'Quinn, Sean .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (02) :187-193
[49]   EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY [J].
Castro, Mario ;
Cook, William ;
Ambrose, Christopher ;
Lindsley, Andrew W. ;
Hunter, Gillian ;
Martin, Neil ;
Ponnarambil, Sandhia .
CHEST, 2022, 162 (04) :35A-36A
[50]   Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma With Aspirin-exacerbated Respiratory Disease: Results From the NAVIGATOR Study [J].
Bernstein, Jonathan ;
Laidlaw, Tanya ;
Buccheit, Kathleen ;
Cahill, Katherine ;
Martin, Nicole ;
Ponnarambil, Sandhia ;
Parikh, Bhavini ;
Ambrose, Christopher ;
Lindsley, Andrew .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) :AB101-AB101
12345